tackling renal cancer with a combination of autologous immunotherapy and sunitinib
Published 9 years ago • 106 plays • Length 6:03Download video MP4
Download video MP3
Similar videos
-
2:34
nivo cabozantinib vs sunitinib for first-line treatment of arcc
-
9:30
study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
4:06
sunitinib with or without surgery for metastatic renal cell carcinoma
-
1:25
dr. tannir on the combination of sunitinib and temsirolimus for metastatic renal cell carcinoma
-
15:21
star: first-line sunitinib or pazopanib in the treatment of locally advanced and/or metastatic r...
-
39:34
immunotherapy in renal cell carcinoma
-
7:20
emerging immunotherapy combinations in kidney cancer
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
6:37
immunotherapy in kidney cancer
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
39:34
10.19.20 urology covid didactics - treating metastatic renal cell carcinoma
-
8:11
implications of using adjuvant sorafenib and sunitinib in unfavourable renal carcinoma
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma